Definition: Zoonotic disease burden quantifies the total impact of diseases transmissible from animals to humans, encompassing their morbidity, mortality, and the associated societal and economic costs.
This burden is a critical public health metric, reflecting the collective health, social, and economic consequences of zoonoses. It includes direct health impacts such as the incidence of illness, severity of disease, disability-adjusted life years (DALYs), and premature mortality. Beyond clinical outcomes, the burden extends to the strain on healthcare systems, productivity losses due to illness or death, and significant economic repercussions on agriculture, trade, and tourism. For instance, outbreaks of diseases like rabies, highly pathogenic avian influenza, or Ebola not only cause human suffering but also lead to extensive culling of animals, market disruptions, and substantial public health expenditure.
Understanding the zoonotic disease burden is paramount for effective public health planning, resource allocation, and policy development, particularly in regions with high human-animal interaction. It highlights the urgent need for a “One Health” approach, integrating human, animal, and environmental health sectors to address the complex drivers of zoonotic emergence and spread, such as deforestation, climate change, urbanization, and global travel. By accurately assessing this burden, public health authorities can prioritize surveillance, implement targeted prevention strategies like vaccination programs and biosecurity measures, and develop rapid response mechanisms to mitigate future outbreaks and protect global health security.
Key Context:
- One Health Approach: An integrated, unifying approach that aims to sustainably balance and optimize the health of people, animals, and ecosystems, crucial for managing zoonotic threats.
- Emerging Infectious Diseases: A significant proportion of these diseases, including novel coronaviruses and highly pathogenic influenzas, have a zoonotic origin, contributing substantially to the overall burden.
- Antimicrobial Resistance (AMR): The use of antimicrobials in both human and animal populations can contribute to the development and spread of resistant pathogens, many of which are zoonotic, complicating treatment and increasing disease burden.